These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2366059)

  • 41. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT.
    Coffey CE; Lucke J; Weiner RD; Krystal AD; Aque M
    Biol Psychiatry; 1995 Jun; 37(11):777-88. PubMed ID: 7647162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dilemma of unmodified electroconvulsive therapy.
    Andrade C; Shah N; Tharyan P
    J Clin Psychiatry; 2003 Oct; 64(10):1147-52. PubMed ID: 14658961
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A successful treatment of drug-resistant depression with electroconvulsive therapy].
    Gieteling M; Hoekstra R; van den Broek WW; Bruijn JA
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2110-2. PubMed ID: 9856226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjustment of anaesthesia depth using bispectral index prolongs seizure duration in electroconvulsive therapy.
    Nishihara F; Saito S
    Anaesth Intensive Care; 2004 Oct; 32(5):661-5. PubMed ID: 15535490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine.
    Turkkal DC; Gokmen N; Yildiz A; Iyilikci L; Gokel E; Sagduyu K; Gunerli A
    J Clin Anesth; 2008 Dec; 20(8):589-93. PubMed ID: 19100931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical value of electroconvulsive therapy in treatment of depression].
    Frey R; Schreinzer D
    Wien Med Wochenschr; 1999; 149(18):525-31. PubMed ID: 10637958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaesthesia for electroconvulsive therapy: use of propofol revisited.
    Fredman B; Husain MM; White PF
    Eur J Anaesthesiol; 1994 Sep; 11(5):423-5. PubMed ID: 7988589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT.
    Akcaboy ZN; Akcaboy EY; Yigitbasł B; Bayam G; Dikmen B; Gogus N; Dilbaz N
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1068-71. PubMed ID: 16095445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy.
    Avramov MN; Husain MM; White PF
    Anesth Analg; 1995 Sep; 81(3):596-602. PubMed ID: 7653829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series.
    Vishne T; Amiaz R; Grunhaus L
    J ECT; 2005 Jun; 21(2):118-21. PubMed ID: 15905755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which depressed patients respond to ECT? The Nottingham results.
    O'Leary D; Gill D; Gregory S; Shawcross C
    J Affect Disord; 1995 Apr; 33(4):245-50. PubMed ID: 7790678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ECT for the treatment of intractable mania in two prepubertal male children.
    Hill MA; Courvoisie H; Dawkins K; Nofal P; Thomas B
    Convuls Ther; 1997 Jun; 13(2):74-82. PubMed ID: 9253527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed amnesia and disorientation after electroconvulsive treatment.
    Grinshpoon A; Mester R; Spivak B; Berg Y; Bleich A; Weizman A
    J Psychiatry Neurosci; 1992 Nov; 17(5):191-3. PubMed ID: 1489760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of vecuronium to prevent suxamethonium-induced myalgia after ECT.
    Herriot PM; Cowain T; McLeod D
    Br J Psychiatry; 1996 May; 168(5):653-4. PubMed ID: 8733812
    [No Abstract]   [Full Text] [Related]  

  • 57. Modifying ECT with a safe, simple and economical technique.
    Joshi VG
    Br J Psychiatry; 1979 Jan; 134():128. PubMed ID: 760916
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
    Bryson EO; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
    Correll CU; Yu X; Xiang Y; Kane JM; Masand P
    Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.
    Medda P; Mauri M; Fratta S; Ciaponi B; Miniati M; Toni C; Dell'Osso L; Perugi G
    J ECT; 2013 Sep; 29(3):179-88. PubMed ID: 23899721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.